Literature DB >> 7609048

Susceptibility to duck hepatitis B virus infection is associated with the presence of cell surface receptor sites that efficiently bind viral particles.

J C Pugh1, Q Di, W S Mason, H Simmons.   

Abstract

To test the hypothesis that susceptibility of hepatocytes to duck hepatitis B virus (DHBV) infection requires cell surface receptors that bind the virus in a specific manner, we developed an assay for the binding of DHBV particles to monolayers of intact cells, using radiolabeled immunoglobulin G specific for DHBV envelope protein. Both noninfectious DHBV surface antigen particles and infectious virions bound to a susceptible fraction (approximately 60%) of Pekin duck hepatocytes. In contrast, binding did not occur to cells that were not susceptible to DHBV infection, including Pekin duck fibroblasts and chicken hepatocytes, and binding to Muscovy duck hepatocytes, which are only weakly susceptible (approximately 1% of cells) to DHBV infection, was virtually undetectable. Within a monolayer, individual Pekin duck hepatocytes appeared to differ markedly in the capacity to bind DHBV, which may explain difficulties that have been encountered in infecting 100% of cells in culture. We have also found that the loss of susceptibility to infection with DHBV that occurs when Pekin duck hepatocytes are maintained for more than a few days in culture correlates with a decline in the number of cells that bind virus particles efficiently. All of these results support the interpretation that the binding event detected by our assay is associated with the interaction between DHBV and specific cell surface receptors that are required for initiation of infection. Our assay may facilitate isolation and identification of hepatocyte receptors for this virus.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7609048      PMCID: PMC189294          DOI: 10.1128/JVI.69.8.4814-4822.1995

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

1.  Virus of Pekin ducks with structural and biological relatedness to human hepatitis B virus.

Authors:  W S Mason; G Seal; J Summers
Journal:  J Virol       Date:  1980-12       Impact factor: 5.103

2.  Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA.

Authors:  M A Sells; M L Chen; G Acs
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

3.  Detection of receptors for hepatitis B virus on cells of extrahepatic origin.

Authors:  A R Neurath; N Strick; P Sproul; H E Ralph; J Valinsky
Journal:  Virology       Date:  1990-06       Impact factor: 3.616

4.  HepG2 cell binding activities of different hepatitis B virus isolates: inhibitory effect of anti-HBs and anti-preS1(21-47).

Authors:  M A Petit; S Dubanchet; F Capel; P Voet; C Dauguet; P Hauser
Journal:  Virology       Date:  1991-02       Impact factor: 3.616

5.  Viral nucleic acid synthesis and antigen accumulation in pancreas and kidney of Pekin ducks infected with duck hepatitis B virus.

Authors:  M S Halpern; J M England; D T Deery; D J Petcu; W S Mason; K L Molnar-Kimber
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

6.  Viral antigen expression in the pancreas of DHBV-infected embryos and young ducks.

Authors:  M S Halpern; S B McMahon; W S Mason; A P O'Connell
Journal:  Virology       Date:  1986-04-15       Impact factor: 3.616

7.  In vitro experimental infection of primary duck hepatocyte cultures with duck hepatitis B virus.

Authors:  J S Tuttleman; J C Pugh; J W Summers
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

8.  Duck hepatitis B virus infection of Muscovy duck hepatocytes and nature of virus resistance in vivo.

Authors:  J C Pugh; H Simmons
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

9.  A cell surface protein that binds avian hepatitis B virus particles.

Authors:  K Kuroki; R Cheung; P L Marion; D Ganem
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

10.  Characterization of a pre-S polypeptide on the surfaces of infectious avian hepadnavirus particles.

Authors:  J C Pugh; J J Sninsky; J W Summers; E Schaeffer
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

View more
  29 in total

1.  Identification of immunodominant and conformational epitopes in the capsid protein of hepatitis E virus by using monoclonal antibodies.

Authors:  M A Riddell; F Li; D A Anderson
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

Review 2.  Avian hepatitis B viruses: molecular and cellular biology, phylogenesis, and host tropism.

Authors:  Anneke Funk; Mouna Mhamdi; Hans Will; Hüseyin Sirma
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

Review 3.  Viral and cellular determinants involved in hepadnaviral entry.

Authors:  Dieter Glebe; Stephan Urban
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

4.  Apoptosis and regeneration of hepatocytes during recovery from transient hepadnavirus infections.

Authors:  J T Guo; H Zhou; C Liu; C Aldrich; J Saputelli; T Whitaker; M I Barrasa; W S Mason; C Seeger
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

5.  Dual topology of the large envelope protein of duck hepatitis B virus: determinants preventing pre-S translocation and glycosylation.

Authors:  I Swameye; H Schaller
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

6.  A hydrophobic domain in the large envelope protein is essential for fusion of duck hepatitis B virus at the late endosome.

Authors:  J Chojnacki; D A Anderson; E V L Grgacic
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

7.  Avian hepatitis B virus infection is initiated by the interaction of a distinct pre-S subdomain with the cellular receptor gp180.

Authors:  S Urban; K M Breiner; F Fehler; U Klingmüller; H Schaller
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

8.  Monoclonal antibodies to a 55-kilodalton protein present in duck liver inhibit infection of primary duck hepatocytes with duck hepatitis B virus.

Authors:  J T Guo; J C Pugh
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

9.  Itinerary of hepatitis B viruses: delineation of restriction points critical for infectious entry.

Authors:  Anneke Funk; Mouna Mhamdi; Li Lin; Hans Will; Hüseyin Sirma
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

10.  Entecavir therapy combined with DNA vaccination for persistent duck hepatitis B virus infection.

Authors:  Wendy K Foster; Darren S Miller; Patricia L Marion; Richard J Colonno; Ieva Kotlarski; Allison R Jilbert
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.